Navigation

Macular degeneration (wet age-related) - aflibercept (1st line) [ID519]

Macular degeneration (wet age-related) - aflibercept (1st line) [ID519]

Status: History
Expected date of issue: July 2013
Referral date: February 2012
Process: STA
Topic area:
  • Eye
 

NICE project team

Executive Lead: TBC
Technical Lead: Matthew Dyer
Communications manager: Shalu Kanal
Project manager: Lori Farrar
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 8 January 2013
1st appraisal committee meeting: 16 April 2013
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Bayer (aflibercept)

Patient/carer groups

  • Macular Society
  • Royal National Institute of Blind People (RNIB)

Professional groups

  • Royal College of Nursing
  • Royal College of Ophthalmologists
  • Royal College of Pathologists

Others

  • Department of Health
  • Bristol, North Somerset and South Gloucestershire (PCT Cluster)
  • Welsh Government

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Healthcare Improvement Scotland

Possible comparator manufacturers

  • Moorfields Pharmaceuticals (bevacizumab)
  • Novartis (ranibizumab, verteporfin)
  • Roche Products (bevacizumab) (CA&U not returned, not participating)
  • Royal Liverpool and Broadgreen University Hospitals NHS Trust Pharmacy (bevacizumab) (CA&U not returned, not participating)

Evidence Review Group

  • Aberdeen HTA Group
  • National Institute for Health Research  Health Technology Assessment Programme

Top


 

Project history

Date Notes
24.07.2013 Guidance publishes
Top


 

Key documents

This page was last updated: 22 July 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.